Cartridges and Capsules

Capsule filters are sealed, single-use devices requiring no separate housing — ideal for smaller batches, pilot-scale work, and rapid changeovers. Cartridge filters are reusable elements installed in stainless steel housings, suited for high-volume, continuous manufacturing. The choice depends on batch size, cleaning validation burden, and regulatory single-use strategy.

Pharmaceutical sterile filtration uses 0.2 µm (or 0.22 µm) rated membranes, which retain Brevundimonas diminuta per ASTM F838-05 and PDA TR26. This pore size removes bacteria and most microorganisms from heat-sensitive drug solutions, APIs, and injectable preparations where terminal sterilisation is not possible, as required by FDA and EU GMP Annex 1.

Pharmaceutical-grade capsule and cartridge filters use polyethersulfone (PES), PVDF, nylon, and PTFE membranes. PES is the most widely used for sterile filtration — offering low protein binding, broad chemical compatibility, and high flux. PTFE suits aggressive solvents and vent filtration; PVDF is preferred for aggressive biologics and high-temperature applications.

GMP filter validation involves extractables and leachables testing, bacterial retention studies (Brevundimonas diminuta per PDA TR26), integrity testing (bubble point or diffusion), and compatibility testing with the process fluid. IQ/OQ/PQ qualification documents the installation and operational performance. Filter manufacturers provide validation guides to support FDA 21 CFR Part 211 and EU GMP compliance.

Extractables are compounds released from filter materials under aggressive test conditions; leachables are those that migrate into drug product under actual process conditions. Regulatory agencies require E&L testing for all filters contacting drug solutions to ensure patient safety, as per USP , ICH Q3D, and FDA/EMA guidance on container closure and filtration systems.

Scale-up pharmaceutical filtration starts with lab-scale sizing studies using Vmax and Pmax testing to determine filter area per litre of process fluid. Capsule filters with consistent membrane lot-to-lot performance allow direct scale-up without revalidation. Cartridge systems in multi-round housings handle commercial volumes while maintaining the same validated membrane grade and qualification status.

Pharmaceutical filtration is governed by FDA 21 CFR Part 211.72 (filters for injectable drug production), EU GMP Annex 1 (sterile medicinal products), and PDA Technical Report 26 (sterilising filtration). Filters must be integrity tested pre- and post-use, validated for bacterial retention, and documented in batch records to demonstrate sterility assurance for each production run.